Affiliation:
1. Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust , London , UK
Abstract
The prescribing of isotretinoin in male patients has become a hot topic of debate in the UK after an independent report from the UK Commission on Human Medicines in October 2023, which resulted in new safety guidance to encourage stricter monitoring of this cohort. We reviewed patients in a tertiary hospital in the UK where an online system has been monitoring genital side-effects and mood for the past 3 years, before this new safety guidance.
Publisher
Oxford University Press (OUP)